Rational use of diagnostic tools in hepatitis C

Journal of Hepatology, Supplement

Volumn 24, Issue 2, 1996, Pages 26-34

  Roggendorf, M ^a   Lu, M ^a   Meisel, H ^b   Riffelmann, M ^b   Schreier, E ^c   Viazov, S ^d  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

^d D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

Author keywords

Diagnostic procedures; Hepatitis C virus

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN M ANTIBODY; INTERFERON; STRUCTURAL PROTEIN; VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS RNA;

ANTIBODY DETECTION; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEROTYPING; VIREMIA; VIRUS GENOME; VIRUS ISOLATION;

EID: 0029814205     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (68)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
2. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina SR, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Houghton M. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451-5.
3. Vernelen K, Claeys H, Verhaert H, Volckaerts A, Vermylen C. Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 1994; 343: 853. .
4. Courouce AM, Bouchardeau F, Girault A, LeMarrec N. Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 1994; 343: 853t.
5. Van der Poel CL, Cuypers HTM, Reesink HW, et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991; 337: 317-9.
6. Goffin E, Pirson Y, Cornu C, Jadoul M, van Ypersele de Strihou C. Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 1994; 343: 854.
7. Garson JA, Tedder RS, Briggs M. Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and predicted infectivity. Lancet .1990; 335: 1419-22.
8. Inchauspe G, Abe K, Zebedee S, Nasoff M, Prince AM. Use of conserved sequences from hepatitis C virus for the detection of viral RNA in infected sera by polymerase chain reaction. Hepatology 1991; 14: 595-600.
9. Okamoto H, Okada S, Sugiyama Y, et al. Detection of hepatitis C virus RNA by a two-staged polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region. Jpn J Exp Med 1990; 60: 215-22.
10. Fuchs K, Motz M, Schreier E, Zachoval R, Deinhardt F, Roggendorf M. Characterization of nucleotide sequences from European hepatitis C virus isolates. Gene 1991; 103: 163-9.
11. Urdea MS, Horn T, Fultz JT, et al. Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. Nucleic Acids Symp Ser 1991; 24: 197-200.
12. Davis GL, Lau JYN, Urdea MS et al. Quantitative detection of hepatitis C virus (HCV) RNA by solid phase branched chain DNA amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 1994; 19: 1337-41.
13. Young KKY, Resnick RM, Myers TW. Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J Clin Microbiol 1993; 31: 8826.
14. Gerken G, Pontisso P, Roggendorf M, Rumi MG, Simmonds P, Trepo C, Zeuzem S, Collucci G. Clinical evaluation of a single reaction, diagnostic PCR assay for the detection of hepatitis C virus (HCV) RNA. J Hepatol 1996; 24: 33-8.
15. Simmonds P, Albert! A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS, Choo QL, Colombo M, Cuypers HTM, Date T, Dusheiko GM, Esteban JI, Fay O, Hadziyannis SJ, Han J, Hatzakis A, Holmes EC, Hotta H, Houghton M, Irvine B, Kohara M, Kolberg JA, Kuo G, Lau JYN, Lelie PN, Maertens G, McOmish F, Miyamura T, Mizokami M, Nomoto A, Prince AM, Reesink HW, Rice C, Roggendorf M, Schalm SW, Shikata T, Shimotohno K, Stuyver L, Trepo C, Weiner A, Yap PL, Urdea MS. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321J.
16. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995;15:41.
17. Chemello L, Albert! A, Rose K, Simmonds P. Hepatitis C serotype and response to Interferon therapy. N Engl J Med 1994; 330: 143.
18. Yoshioka K, Kakumu S, Wakita T, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotype virus. J Hepatol 1992; 16: 293-9.
19. Martell M, Esteban J, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992; 66: 3225-9.
20. Lu M, Punsch B, Wiese M, Roggendorf M. Analysis of hepatitis C virus quasispecies populations by temperature gradient gel electrophoresis. J Gen Virol 1995; 76: 881-7.
21. Francis B, Gitnick G, Taboada F, Andiorio E, Oco J, Rojas J, Botsko E, Achord D, DiNello R, Quan S, Polito A, Nelles M, Lee S. Improved detection of anti-HCV seroconversion by a prototype HCV 3.0 Elisa. Transfusion 1993; Suppl. 33: 32.
22. Lee SR, Barrera JM, Ercilla G, Francis B, Nelles M. Improved detection of anti HCV in post-transfusion NANBH patients by a prototype HCV 3.0 Elisa. Transfusion 1993; Suppl. 33: 32.
23. Francis B, Tyboada F, Andiorio E, Oco J, Bahl C, Kochesky R, Page E, Rolon N, Achord D, DiNello R, Quan S, Wilbur J, Polito A, Wiltbank T, Cyrus S, Alfrey C, Fortenberry D, Kobuszewski M, Balshmveit G, Nelles M, Lee S. Demonstration of improved sensitivity and specificity in blood donors by a prototype HCV 3.0 Elisa. Transfusion 1993; Suppl. 33: 32.
24. Knoedler B, Kiihnl P, Hiller J. Antibodies to the non-structural region 5 (NS5) of the hepatitis C virus (HCV) in German blood donors. Transfusion 1993; Suppl. 33: 33.
25. Mita E, Hayashi N, Ueda K, Kasahara A, Fusamoto H, Takamizawa A, Matsubara K, Okayama H, Kamada T. Expression of MBP-HCV NS1/E2 fusion protein in E.coli and detection of anti-NSl/E2 antibody in type C chronic liver disease. Biochem Biophys Res Commun 1992; 183: 925-30.
26. Lesniewski R, Okasinski G, Carrick R, Van Sant C, Desai S, Johnson R, Scheffel J, Moore B, Mushahwar I. Antibody to hepatitis C virus second envelope (HCV-E2) glycoprotein: a new marker of HCV infection closely associated with viremia. J Med Virol 1995; 45: 415-22.
27. Meisel H, Reimer K, Reip A, Porst H, Krüger DH, Roggendorf M. Longterm follow-up of viraemia and patterns of immune response to HCV in patients with asymptomatic, acute self-limited and chronic hepatitis C after treatment with contaminated anti-D. In preparation.
28. Alter HJ. The hepatitis C virus and its relationsip to the clinical spectrum of NANB hepatitis. J Gastroenterol Hepatol 1990; Suppl 1: 78-94.
29. Clemens JM, Taskar S, Chau K, Vallari D, Wai-Kuo Shih J, Alter HJ, Schleicher JB, Mimms LT. IgM antibody response in acute hepatitis C viral infection. Blood 1992; 79: 169-72.
30. Kikuchi, T, Onji M, Michitaka K, Saito I, Miyamura T, Ohta Y. Anti-HCV immunoglobulin-M antibody in patients with hepatitis C. J Gastroenterol Hepatol 1992; 7: 246-8.
31. Hellström ÜB, Sylvan SPE, Decker RH, Sönnerborg A. Immunoglobulin M reactivity towards the immunologically active region sp75 of the core protein of hepatitis C virus (HCV) in chronic HCV infection. J Med Virol 1993; 39: 32532.
32. Bukh J, Wantzin P, Krogsgaard K, Knudsen F, Purcell R.H, Miller RH, and the Copenhagen Dialysis HCV Study Group. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. J Infect Dis 1993; 168: 1343-8.
33. Silini E, Bono F, Cerino A, Piazza V, Solcia E, Mondelli MU. Virological features of hepatitis C virus infection in hemodialysis patients. J Clin Microbiol 1993; 31: 2913-7.
34. Gabriel C, Blauhut B. Comparison of seven anti-HCV Enzymeimmunoassays of the second generation used in the blood transfusion setting. Transfusionsmedizin 1993; 31: 1620.
35. Courouce AM, LeMarrec N, Girault A, Ducamp S, Simon N. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays. Transfusion 1994; 34: 790-5.
36. Dow BC, Follett EAC, Jordan T, et al. Testing of blood donations for hepatitis C virus. Lancet 1994; 343: 477-8.
37. Dittmann S, Roggendorf M, Dürkop J, Wiese M, Lorbeer B, Deinhardt F. Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatol 1991; 13: 323-7.
38. Meisel H, Reip A, Faltus B, Lu M, Porst H, Wiese M, Roggendorf M, Krüger DH. Transmission of hepatitis C virus by women infected from a single source to their children and husbands. Lancet 1995; 345: 1209-11.
39. Schlipköter U, Gladziwa U, Cholmakos K, Weise A, Rasshofer R, Lorbeer B, Luz N, Deinhardt F, Roggendorf M. Prevalence of hepatitis C virus infections in dialysis patients and their contacts using a second generation enzyme-linked immunosorbent assay. Med Microbiol Immunol 1992; 181: 173-80.
40. Zibert.A, Schreier E, Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virol 1995; 208: 653-61.
41. Zaaijer HL, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 7221.
42. Damen M, Cuypers HTM, Zaaijer HL, Reesink HW, Schaasberg WP, Gerlich WH, Niesters HGM, Lelie PN. Second international quality control study on the Eurohep HCV-RNA reference panel. J Clin Microbiol 1996; in press.
43. Tsobuta, Chayama K, Ikeda K, et al. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 1994; 19: 1088-94.
44. Ohio H, Terazawa S, Sasaki N, Sasaki N, Hino K, Ishiwata C, Kako M, Ujiie, N, Endo C, Matsui A, Okamato H, Mishiro S, and the vertival transmission of hepatitis C virus collaborative study group. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994; 330: 744-50.
45. Collins ML, Zayati C, Detmer JJ, et al. Preparation and characterization of RNA standards for use in branched DNA hybridization assays. Ann Biochem. 1995; 226: 1209.
46. Lau J, Davis G, Kniffen J, Quian K-P, Urdea M, Chan C, Mizokami M, Neuwald P, Wilber J. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: ISOlt.
47. Lau JYN, Simmonds P, Urdea MS. Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet 1995; 346: 425-6.
48. Bukh J, Purcell RH, Miller RH. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative El gene of isolates collected worldwide. Proc Natl Acad Sci USA 1993; 90: 8234-8.
49. Bukh J, Purcell RH, Miller RH. Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci USA 1994; 91: 82393.
50. Simmonds P, Rose KA, Graham S, Chan S-W, McOmish F, Dow BC, Follett EAC, Yap PL, Marsden H. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol 1993; 31: 1493-503.
51. Simmonds P, McOmish F, Yap PL, Chan SW, Lin CK, Dusheiko G, Saeed AA, Holmes EC. Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol 1993; 74: 661-8.
52. Tokita H, Okamoto H, Tsuda F, Song P, Nakata S, Chosa T, lizuka H, Mishiro S, Miyakawa Y, Mayumi J. Hepatitis C virus variants from Vietnam are classificable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci USA 1994; 91: 11022-6.
53. Davidson R, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett C, Seed CRG, Krusius T, Lin C, Medgyesi GA, Kiyokawa H, Olim G, Duraisamy G, Cuypers T, Saeed AA, Teo D, Conradie J, Kew MC, Lin M, Nuchaprayoon C, Ndimbie OK, Yap PL. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol 1995; 76: 1197204.
54. McOmish F, Chan SW, Dow BC, Gillon J, Frame WD, Crawford RJ, Yap PL, Follett EAC, Simmonds P. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in sérologie reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993; 33: 7-13.
55. Driesel G, Wirth D, Stark K, Baumgarten R, Sucker U, Schreier E. Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region. Arch Virol 1994; 139: 379-88.
56. Nakao T, Enomoto N, Takada N, Takada A,'Date T. Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J Gen Virol 1991; 72: 2105-12.
57. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093-102.
58. Viazov S, Zibert A, Ramakrishnan K, Widell A, Cavacchini A, Schreier E, Roggendorf M. Typing of hepatitis C virus isolates by DNA enzyme immunoassay. J Virol Method 1994; 48: 81-91.
59. Bhattacherjee V, Prescott LE, Pike I, Rodgers B, Bell H, ElZayadi AR, Kew MC, Conradie J, Lin CK, Marsden H, Parker D, Yap PL, Simmonds P. Use of NS4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5, and 6. J Gen Virol 1996; in press.
60. Okamoto H, Sugiuama Y, Okada SI, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 6739.
61. Lau JYN, Mizokami M, Kolberg JA, Davis GL, Prescott LE, Ohno T, Perrillo RP, Lindsay KL, Gish RG, Qian KP, Kohara M, Simmonds P, Urdea MS. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995; 171: 281-9.
62. McOmish F, Yap PL, Dow BC, Follett EAC, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R, Lin C, Lai C, Leong S, Medgyesi GA, Hejjas M, Kiyokawa H, Fukada K, Cuypers T. Saeed AA, Alrasheed AM, Lin M, Simmonds P. Geographical distribution of hepatitis C virus genotypes in blood donors - an international collaborative survey. J Clin Microbiol 1994; 32: 884-92.
63. Stark K, Schreier E, Driesel G, Müller R, Wirth D, Bienzle U. Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin. Scand J Infect Dis 1995; 27: 331-7.
64. Schreier E, Roggendorf M, Dreisei G, Hohne M, Viazov S. Genotypes of hepatitis C virus isolated from different parts of the world. Arch Virol 1996, in press.
65. Lu M, Wiese M, Punsch B, Roggendorf M. Different susceptibilities of genetic variants of hepatitis C virus (HCV) to interferon (IFN). Arch Virol 1996; in press.
66. Widell A, Shev S, Mansson S, Zhang YY, Foberg U, Norkrans G, Fryden A, Weiland O, Kirkus J, Nordenfeit E. Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications. J Med Virol 1994; 44: 272-9.
67. Shev S, Widell A, Foberg U, Fryden A, Hermodsson S, Lindh G, Lindholm A, Mansson S, Weiland O, Norkrans G. HCV genotypes in Swedish blood donors as correlated to epidemiology of liver disease and hepatitis C virus antibody profile. Infection 1995; 23: 253-7.
68. Uyttendaele S, Claeys H, Mertens W, Verhaert H, Vermylen C. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang 1994; 66: 122-9.